[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-five-day-fasting-mimicking-diet-shows-promise-for-crohn-s-disease-relief-en":3,"ArticleBody_S5YrdGiLMdqTZMMcPhWOPaxKW8GFuMoYCJId36XBwSk":145},{"article":4,"relatedArticles":137,"locale":41},{"id":5,"title":6,"slug":7,"content":8,"htmlContent":9,"excerpt":10,"category":11,"tags":12,"metaDescription":10,"wordCount":13,"readingTime":14,"publishedAt":15,"sources":16,"sourceCoverage":34,"transparency":35,"seo":38,"language":41,"featuredImage":42,"featuredImageCredit":43,"isFreeGeneration":47,"niche":48,"geoTakeaways":52,"geoFaq":61,"entities":71},"69d245a2b3b92dfc3f9f296a","Five-Day Fasting-Mimicking Diet Shows Promise for Crohn’s Disease Relief","five-day-fasting-mimicking-diet-shows-promise-for-crohn-s-disease-relief","For many people with [Crohn’s disease](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FCrohn's_disease), diet feels like a missing treatment piece. A new [Stanford](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FStanford_University)-led [randomized clinical trial](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FRandomized_controlled_trial) suggests a structured, five-day‑a‑month fasting-mimicking diet (FMD) can improve symptoms and gut inflammation in adults with mild-to-moderate disease.[2][4] Kulkarni et al. (2026, *[Nature Medicine](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FNature_Medicine)*)[4] found this approach can be added to standard medications, not used instead of them.\n\nUnlike long-term restrictive diets, this strategy compresses calorie restriction into short, repeatable cycles.[1][2] It is intensive and not appropriate for everyone, especially those with weight loss or malnutrition.[1][2]  \n\n💡 **Key takeaway:** A short, supervised diet program can influence Crohn’s symptoms and biology—but it is not a do‑it‑yourself cure.\n\n---\n\n## What the five-day fasting-mimicking trial found\n\nThe trial enrolled 97 U.S. adults with mild-to-moderate Crohn’s disease.[1][4]  \n\n- **FMD group:** 65 participants followed a five-day, plant-based, low‑calorie plan once a month for three months, returning to usual eating in between.[1][4]  \n- **Control group:** 32 participants continued their usual baseline diet.[1][4]  \n- **Both groups:** Stayed on their prescribed Crohn’s medications throughout.[2][4]  \n\n📊 **Clinical response and remission**\n\nPrimary outcome: clinical response, defined as ≥70‑point drop in CDAI or CDAI ≤150 after the third five-day cycle.[4]  \n\n- **Clinical response:**  \n  - 69.2% in the FMD group[4]  \n  - 43.8% in the control group[4]  \n- **Clinical remission (secondary outcome):**  \n  - 64.6% in the FMD group[4]  \n  - 37.5% in the control group[4]  \n\nThese findings suggest the five-day intervention often reduced disease activity to low levels.[4]\n\nIn practical terms, about two‑thirds of people on FMD reported:  \n\n- Less diarrhea, abdominal pain, and cramping by three months[1][2][3][4]  \n- Noticeable relief for many after just one cycle[1][2][3][4]  \n- Fewer bowel movements and milder pain by the second month[1][4]  \n\n⚠️ **Key point:** Some control patients also improved, reflecting Crohn’s natural ups and downs and highlighting the need for controlled trials to test diets.[1][4]\n\n---\n\n## How the fasting-mimicking diet works—and what made this trial stand out\n\nA fasting-mimicking diet is a carefully designed, mainly plant-based plan that sharply cuts calories for a few days while still allowing food.[1][2] The aim is to trigger a “fasting-like” metabolic state—altering fuel use and inflammatory signaling—without water-only fasting or extreme, unsupervised restriction.[2][3]  \n\nIn this trial, participants consumed about **700–1,100 calories per day** during each five-day cycle, mostly from plant-based meals.[1][3][4] For the remaining ~25 days, they returned to their usual diets, repeating this monthly for three months.[1][3][4]\n\n📊 **Biological changes**\n\nResearchers measured objective markers of gut inflammation.[4] Compared with controls, the FMD group showed:  \n\n- **22% median decrease** in fecal calprotectin (stool marker of intestinal inflammation)[4]  \n- **8% median increase** in fecal calprotectin in the control group[4]  \n- Decreases in [inflammatory lipid mediators](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FSpecialized_pro-resolving_mediators) and immune-effector gene transcripts[4]  \n\nThese changes suggest effects on underlying inflammatory pathways, not just symptom perception.[3][4]\n\nThis was the largest randomized controlled oral diet trial in adults with Crohn’s disease, in a field long dominated by small or lower-quality diet studies despite high patient interest.[2] Lead investigator Dr. Sidhartha Sinha noted the team was “very pleasantly surprised” that a majority benefited and that some gains appeared after just one cycle.[1][3][4]\n\n💡 **Key takeaway:** The FMD trial stands out for its size, randomized design, and biological data, shifting diet from speculation toward an evidence-based Crohn’s strategy.[2][4]\n\n---\n\n## Who might benefit, safety concerns, and next steps\n\nThe study focused on adults with **mild-to-moderate** Crohn’s disease.[2][4] It did **not** target people with:  \n\n- Severe disease  \n- Recent surgery  \n- Significant malnutrition  \n- Complications such as strictures or fistulas[2][4]  \n\nAggressive calorie restriction can be risky in Crohn’s, where many already face:[1][2]  \n\n- Unintended weight loss  \n- Poor appetite  \n- Nutrient deficiencies  \n\nPotential harms of FMD include:  \n\n- Further weight loss  \n- Worsening malnutrition  \n- Dehydration, especially with ongoing diarrhea[1]  \n\n⚠️ **Key point:** FMD was used **in addition to**, not instead of, biologics or immunosuppressants.[2][4] No participants stopped prescribed treatment; doing so without guidance could trigger severe flares or complications.[1][2]\n\nAnyone considering this approach should work with a gastroenterologist and registered dietitian to:  \n\n- Assess suitability and nutritional risks  \n- Monitor weight, labs, and symptoms  \n- Set clear stop rules (e.g., rapid weight loss, severe fatigue, worsening pain)  \n\n💡 **Key takeaway:** This diet should only be attempted under professional supervision, especially for people underweight, recently hospitalized, or struggling to meet calorie needs.[1][2]\n\n---\n\n## Conclusion: Promising data, careful use\n\nA five-day‑a‑month fasting-mimicking diet, repeated for three months, produced higher clinical response and remission rates than a usual diet in adults with mild-to-moderate Crohn’s disease, along with reductions in fecal calprotectin and other inflammatory markers.[1][3][4]  \n\nAt the same time, it is an intensive, calorie-restricted program with real risks if used unsupervised. The trial supports diet as a meaningful adjunct—not a replacement—for standard Crohn’s therapy and points toward a future where structured, evidence-based nutrition plays a clearer role in disease management.[1][2][4]","\u003Cp>For many people with \u003Ca href=\"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FCrohn's_disease\" class=\"wiki-link\" target=\"_blank\" rel=\"noopener\">Crohn’s disease\u003C\u002Fa>, diet feels like a missing treatment piece. A new \u003Ca href=\"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FStanford_University\" class=\"wiki-link\" target=\"_blank\" rel=\"noopener\">Stanford\u003C\u002Fa>-led \u003Ca href=\"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FRandomized_controlled_trial\" class=\"wiki-link\" target=\"_blank\" rel=\"noopener\">randomized clinical trial\u003C\u002Fa> suggests a structured, five-day‑a‑month fasting-mimicking diet (FMD) can improve symptoms and gut inflammation in adults with mild-to-moderate disease.\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa> Kulkarni et al. (2026, \u003Cem>\u003Ca href=\"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FNature_Medicine\" class=\"wiki-link\" target=\"_blank\" rel=\"noopener\">Nature Medicine\u003C\u002Fa>\u003C\u002Fem>)\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa> found this approach can be added to standard medications, not used instead of them.\u003C\u002Fp>\n\u003Cp>Unlike long-term restrictive diets, this strategy compresses calorie restriction into short, repeatable cycles.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa> It is intensive and not appropriate for everyone, especially those with weight loss or malnutrition.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>💡 \u003Cstrong>Key takeaway:\u003C\u002Fstrong> A short, supervised diet program can influence Crohn’s symptoms and biology—but it is not a do‑it‑yourself cure.\u003C\u002Fp>\n\u003Chr>\n\u003Ch2>What the five-day fasting-mimicking trial found\u003C\u002Fh2>\n\u003Cp>The trial enrolled 97 U.S. adults with mild-to-moderate Crohn’s disease.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cul>\n\u003Cli>\u003Cstrong>FMD group:\u003C\u002Fstrong> 65 participants followed a five-day, plant-based, low‑calorie plan once a month for three months, returning to usual eating in between.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>\u003Cstrong>Control group:\u003C\u002Fstrong> 32 participants continued their usual baseline diet.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>\u003Cstrong>Both groups:\u003C\u002Fstrong> Stayed on their prescribed Crohn’s medications throughout.\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>📊 \u003Cstrong>Clinical response and remission\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>Primary outcome: clinical response, defined as ≥70‑point drop in CDAI or CDAI ≤150 after the third five-day cycle.\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cul>\n\u003Cli>\u003Cstrong>Clinical response:\u003C\u002Fstrong>\n\u003Cul>\n\u003Cli>69.2% in the FMD group\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>43.8% in the control group\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003C\u002Ful>\n\u003C\u002Fli>\n\u003Cli>\u003Cstrong>Clinical remission (secondary outcome):\u003C\u002Fstrong>\n\u003Cul>\n\u003Cli>64.6% in the FMD group\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>37.5% in the control group\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003C\u002Ful>\n\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>These findings suggest the five-day intervention often reduced disease activity to low levels.\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>In practical terms, about two‑thirds of people on FMD reported:\u003C\u002Fp>\n\u003Cul>\n\u003Cli>Less diarrhea, abdominal pain, and cramping by three months\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>Noticeable relief for many after just one cycle\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>Fewer bowel movements and milder pain by the second month\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>⚠️ \u003Cstrong>Key point:\u003C\u002Fstrong> Some control patients also improved, reflecting Crohn’s natural ups and downs and highlighting the need for controlled trials to test diets.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Chr>\n\u003Ch2>How the fasting-mimicking diet works—and what made this trial stand out\u003C\u002Fh2>\n\u003Cp>A fasting-mimicking diet is a carefully designed, mainly plant-based plan that sharply cuts calories for a few days while still allowing food.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa> The aim is to trigger a “fasting-like” metabolic state—altering fuel use and inflammatory signaling—without water-only fasting or extreme, unsupervised restriction.\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>In this trial, participants consumed about \u003Cstrong>700–1,100 calories per day\u003C\u002Fstrong> during each five-day cycle, mostly from plant-based meals.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa> For the remaining ~25 days, they returned to their usual diets, repeating this monthly for three months.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>📊 \u003Cstrong>Biological changes\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>Researchers measured objective markers of gut inflammation.\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa> Compared with controls, the FMD group showed:\u003C\u002Fp>\n\u003Cul>\n\u003Cli>\u003Cstrong>22% median decrease\u003C\u002Fstrong> in fecal calprotectin (stool marker of intestinal inflammation)\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>\u003Cstrong>8% median increase\u003C\u002Fstrong> in fecal calprotectin in the control group\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003Cli>Decreases in \u003Ca href=\"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FSpecialized_pro-resolving_mediators\" class=\"wiki-link\" target=\"_blank\" rel=\"noopener\">inflammatory lipid mediators\u003C\u002Fa> and immune-effector gene transcripts\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>These changes suggest effects on underlying inflammatory pathways, not just symptom perception.\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>This was the largest randomized controlled oral diet trial in adults with Crohn’s disease, in a field long dominated by small or lower-quality diet studies despite high patient interest.\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa> Lead investigator Dr. Sidhartha Sinha noted the team was “very pleasantly surprised” that a majority benefited and that some gains appeared after just one cycle.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>💡 \u003Cstrong>Key takeaway:\u003C\u002Fstrong> The FMD trial stands out for its size, randomized design, and biological data, shifting diet from speculation toward an evidence-based Crohn’s strategy.\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Chr>\n\u003Ch2>Who might benefit, safety concerns, and next steps\u003C\u002Fh2>\n\u003Cp>The study focused on adults with \u003Cstrong>mild-to-moderate\u003C\u002Fstrong> Crohn’s disease.\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa> It did \u003Cstrong>not\u003C\u002Fstrong> target people with:\u003C\u002Fp>\n\u003Cul>\n\u003Cli>Severe disease\u003C\u002Fli>\n\u003Cli>Recent surgery\u003C\u002Fli>\n\u003Cli>Significant malnutrition\u003C\u002Fli>\n\u003Cli>Complications such as strictures or fistulas\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>Aggressive calorie restriction can be risky in Crohn’s, where many already face:\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cul>\n\u003Cli>Unintended weight loss\u003C\u002Fli>\n\u003Cli>Poor appetite\u003C\u002Fli>\n\u003Cli>Nutrient deficiencies\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>Potential harms of FMD include:\u003C\u002Fp>\n\u003Cul>\n\u003Cli>Further weight loss\u003C\u002Fli>\n\u003Cli>Worsening malnutrition\u003C\u002Fli>\n\u003Cli>Dehydration, especially with ongoing diarrhea\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>⚠️ \u003Cstrong>Key point:\u003C\u002Fstrong> FMD was used \u003Cstrong>in addition to\u003C\u002Fstrong>, not instead of, biologics or immunosuppressants.\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa> No participants stopped prescribed treatment; doing so without guidance could trigger severe flares or complications.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>Anyone considering this approach should work with a gastroenterologist and registered dietitian to:\u003C\u002Fp>\n\u003Cul>\n\u003Cli>Assess suitability and nutritional risks\u003C\u002Fli>\n\u003Cli>Monitor weight, labs, and symptoms\u003C\u002Fli>\n\u003Cli>Set clear stop rules (e.g., rapid weight loss, severe fatigue, worsening pain)\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp>💡 \u003Cstrong>Key takeaway:\u003C\u002Fstrong> This diet should only be attempted under professional supervision, especially for people underweight, recently hospitalized, or struggling to meet calorie needs.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003C\u002Fp>\n\u003Chr>\n\u003Ch2>Conclusion: Promising data, careful use\u003C\u002Fh2>\n\u003Cp>A five-day‑a‑month fasting-mimicking diet, repeated for three months, produced higher clinical response and remission rates than a usual diet in adults with mild-to-moderate Crohn’s disease, along with reductions in fecal calprotectin and other inflammatory markers.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-3\" class=\"citation-link\" title=\"View source [3]\">[3]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n\u003Cp>At the same time, it is an intensive, calorie-restricted program with real risks if used unsupervised. The trial supports diet as a meaningful adjunct—not a replacement—for standard Crohn’s therapy and points toward a future where structured, evidence-based nutrition plays a clearer role in disease management.\u003Ca href=\"#source-1\" class=\"citation-link\" title=\"View source [1]\">[1]\u003C\u002Fa>\u003Ca href=\"#source-2\" class=\"citation-link\" title=\"View source [2]\">[2]\u003C\u002Fa>\u003Ca href=\"#source-4\" class=\"citation-link\" title=\"View source [4]\">[4]\u003C\u002Fa>\u003C\u002Fp>\n","For many people with Crohn’s disease, diet feels like a missing treatment piece. A new Stanford-led randomized clinical trial suggests a structured, five-day‑a‑month fasting-mimicking diet (FMD) can i...","trend-radar",[],789,4,"2026-04-05T11:26:13.402Z",[17,22,26,30],{"title":18,"url":19,"summary":20,"type":21},"Low-Calorie, Fasting-Mimicking Diet May Benefit Those With Crohn's Disease","https:\u002F\u002Fwww.healthline.com\u002Fhealth-news\u002Ffasting-mimicking-diet-improves-crohns-disease","A fasting-mimicking diet may help improve symptoms of Crohn’s disease. Image Credit: Lawren Lu\u002FStocksy\n\n- A short-term calorie deficit may be beneficial for people with Crohn’s disease.\n- Research sug...","kb",{"title":23,"url":24,"summary":25,"type":21},"A Five-Day-a-Month Diet Shows Promise for Crohn’s Disease Relief","https:\u002F\u002Fmed.stanford.edu\u002Fmedicine\u002Fnews\u002Fcurrent-news\u002Fstandard-news\u002Fcrohns-5day-diet.html","A Five-Day-a-Month Diet Shows Promise for Crohn’s Disease Relief\n\nArtwork courtesy of DALL-E.\n\nJanuary 13, 2026 - By Rebecca Handler\n\nFor people living with Crohn’s disease, a common question often go...",{"title":27,"url":28,"summary":29,"type":21},"Two-Thirds Of Crohn's Disease Patients Benefit From Fasting Diet, Clinical Trial Shows","https:\u002F\u002Fwww.powershealth.org\u002Fabout-us\u002Fnewsroom\u002Fhealth-library\u002F2026\u002F01\u002F14\u002Ftwothirds-of-crohns-disease-patients-benefit-from-fasting-diet-clinical-trial-shows","WEDNESDAY, Jan. 14, 2026 (HealthDay News) — Fasting a handful of days each month can significantly improve GI symptoms among people with Crohn’s disease.\n\nThe new approach, called “fasting mimicking,”...",{"title":31,"url":32,"summary":33,"type":21},"Fasting-Mimicking Diet Beneficial in Mild-to-Moderate Crohn Disease - Gastroenterology Advisor","https:\u002F\u002Fwww.gastroenterologyadvisor.com\u002Fnews\u002Ffasting-mimicking-diet-beneficial-in-mild-to-moderate-crohn-disease\u002F","HealthDay News — A fasting-mimicking diet (FMD) is beneficial for induction of clinical response and clinical remission in patients with mild-to-moderate Crohn disease (CD), according to a study publi...",{"totalSources":14},{"generationDuration":36,"kbQueriesCount":14,"confidenceScore":37,"sourcesCount":14},70839,92,{"metaTitle":39,"metaDescription":40},"Fasting-mimicking diet benefits Crohn’s: 5-day cycles","New Stanford trial: five-day fasting-mimicking cycles eased Crohn’s symptoms and inflammation; added to meds. Learn who can try it and why it worked.","en","https:\u002F\u002Fimages.unsplash.com\u002Fphoto-1767972159709-52936afffdbf?ixid=M3w4OTczNDl8MHwxfHNlYXJjaHwxfHxmaXZlJTIwZGF5JTIwZmFzdGluZyUyMG1pbWlja2luZ3xlbnwxfDB8fHwxNzc1MzQxMzMwfDA&ixlib=rb-4.1.0&w=1200&h=630&fit=crop&crop=entropy&auto=format,compress&q=60",{"photographerName":44,"photographerUrl":45,"unsplashUrl":46},"Sasun Bughdaryan","https:\u002F\u002Funsplash.com\u002F@sasun1990?utm_source=coreprose&utm_medium=referral","https:\u002F\u002Funsplash.com\u002Fphotos\u002Falarm-clock-on-a-plate-with-cutlery-a1hU8-woqFA?utm_source=coreprose&utm_medium=referral",true,{"key":49,"name":50,"nameEn":51},"sante","Santé & Médecine","Health & Medicine",[53,55,57,59],{"text":54},"A five-day‑per‑month fasting‑mimicking diet (700–1,100 kcal\u002Fday) for three months produced a 69.2% clinical response rate and 64.6% clinical remission rate in adults with mild‑to‑moderate Crohn’s disease versus 43.8% response and 37.5% remission in controls.",{"text":56},"The FMD group had a 22% median decrease in fecal calprotectin versus an 8% median increase in controls, demonstrating objective reduction in intestinal inflammation.",{"text":58},"The intervention was studied as an adjunct to standard Crohn’s medications; no participants stopped prescribed treatments during the trial.",{"text":60},"The protocol is intensive and unsafe for people with severe disease, recent surgery, significant malnutrition, or ongoing unintended weight loss; it requires clinician and dietitian supervision.",[62,65,68],{"question":63,"answer":64},"What exactly did the randomized trial of the five‑day fasting‑mimicking diet find?","The trial demonstrated that monthly five‑day FMD cycles (700–1,100 kcal\u002Fday, plant‑based) for three months increased clinical response to 69.2% and clinical remission to 64.6% compared with 43.8% and 37.5% in a usual‑diet control group. The study enrolled 97 adults with mild‑to‑moderate Crohn’s disease and measured objective biomarkers: the FMD group had a 22% median reduction in fecal calprotectin while controls had an 8% median increase, along with decreases in inflammatory lipid mediators and immune‑related gene transcripts. Those results indicate symptom improvement plus biological evidence of reduced gut inflammation.",{"question":66,"answer":67},"Who with Crohn’s disease is an appropriate candidate for the FMD used in the trial?","Appropriate candidates are adults with mild‑to‑moderate Crohn’s disease who are not malnourished, have not had recent surgery, and do not have complications such as strictures or fistulas. The trial excluded people with severe disease, significant unintended weight loss, or major nutritional deficiencies because the diet is calorie‑restricted (700–1,100 kcal\u002Fday) and can exacerbate malnutrition. Any candidate should be assessed by their gastroenterologist and a registered dietitian to confirm nutritional status, establish monitoring plans (weight, labs, calprotectin), and define stop rules for rapid weight loss or clinical deterioration.",{"question":69,"answer":70},"How should the FMD be used relative to Crohn’s medications and clinical care?","The FMD must be used as an adjunct, not a replacement, for prescribed Crohn’s therapies. In the trial, participants remained on their usual biologics or immunosuppressants throughout the study; no medications were stopped. Clinicians should coordinate the diet with medical management, monitor for dehydration, weight loss, and symptom worsening, and adjust care if complications arise. Attempting FMD without medical supervision or stopping immunosuppressive therapy risks severe flares, disease progression, and avoidable complications.",[72,78,83,88,92,96,100,104,108,111,116,121,126,130,133],{"id":73,"name":74,"type":75,"confidence":76,"wikipediaUrl":77},"69d190204eea09eba3dfe80c","Fasting-mimicking diet","concept",0.99,"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FThe_Longevity_Diet",{"id":79,"name":80,"type":75,"confidence":81,"wikipediaUrl":82},"69d190214eea09eba3dfe812","Fecal calprotectin",0.97,"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FFaecal_calprotectin",{"id":84,"name":85,"type":75,"confidence":86,"wikipediaUrl":87},"69d1a43e4eea09eba3dfe9f3","CDAI",0.95,null,{"id":89,"name":90,"type":75,"confidence":91,"wikipediaUrl":87},"69d19c0e4eea09eba3dfe926","immune-effector gene transcripts",0.88,{"id":93,"name":94,"type":75,"confidence":91,"wikipediaUrl":95},"69d19c0e4eea09eba3dfe925","inflammatory lipid mediators","https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FSpecialized_pro-resolving_mediators",{"id":97,"name":98,"type":75,"confidence":99,"wikipediaUrl":87},"69d246f54eea09eba3dff5a9","biologics",0.9,{"id":101,"name":102,"type":75,"confidence":76,"wikipediaUrl":103},"69d246f44eea09eba3dff5a6","Crohn’s disease","https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FCrohn's_disease",{"id":105,"name":106,"type":75,"confidence":107,"wikipediaUrl":87},"69d246f74eea09eba3dff5ae","calorie intake (per FMD day)",0.98,{"id":109,"name":110,"type":75,"confidence":99,"wikipediaUrl":87},"69d246f64eea09eba3dff5aa","immunosuppressants",{"id":112,"name":113,"type":114,"confidence":86,"wikipediaUrl":115},"69d246f54eea09eba3dff5a7","randomized clinical trial","event","https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FRandomized_controlled_trial",{"id":117,"name":118,"type":119,"confidence":86,"wikipediaUrl":120},"69d190214eea09eba3dfe80f","Nature Medicine","organization","https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FNature_Medicine",{"id":122,"name":123,"type":119,"confidence":124,"wikipediaUrl":125},"69d190204eea09eba3dfe80e","Stanford",0.92,"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FStanford_University",{"id":127,"name":128,"type":129,"confidence":86,"wikipediaUrl":87},"69d190214eea09eba3dfe813","Gastroenterologist","other",{"id":131,"name":132,"type":129,"confidence":99,"wikipediaUrl":87},"69d1a43f4eea09eba3dfe9f6","registered dietitian",{"id":134,"name":135,"type":129,"confidence":136,"wikipediaUrl":87},"69d246f64eea09eba3dff5ac","FMD group",0.96,[138],{"id":139,"title":140,"slug":141,"excerpt":142,"category":11,"featuredImage":143,"publishedAt":144},"69d48127fc9a83011893c2c3","How Digital Heart Twins Guided Successful VT Ablation in 10 Patients","how-digital-heart-twins-guided-successful-vt-ablation-in-10-patients","From Ventricular Tachycardia to Digital Heart Twins: Why This Trial Matters\n\nVentricular tachycardia (VT) is a rapid rhythm from the heart’s lower chambers that can degenerate into ventricular fibrill...","https:\u002F\u002Fimages.unsplash.com\u002Fphoto-1739185253617-4fdc1cd3d62a?ixid=M3w4OTczNDl8MHwxfHNlYXJjaHwxfHxkaWdpdGFsJTIwaGVhcnQlMjB0d2lucyUyMGd1aWRlZHxlbnwxfDB8fHwxNzc1NTM0Mzc1fDA&ixlib=rb-4.1.0&w=1200&h=630&fit=crop&crop=entropy&auto=format,compress&q=60","2026-04-07T04:07:18.077Z",["Island",146],{"key":147,"params":148,"result":150},"ArticleBody_S5YrdGiLMdqTZMMcPhWOPaxKW8GFuMoYCJId36XBwSk",{"props":149},"{\"articleId\":\"69d245a2b3b92dfc3f9f296a\"}",{"head":151},{}]